Characteristic | All (N = 1432) | Gynecomastia (n = 73) |
---|---|---|
Demographics | ||
Age (years), median (IQR) | 40 (38–48) | 40 (33–48) |
Baseline CD4 count median (IQR) | 260 (126–412) | 318 (192–469) |
Baseline BMI, median (IQR) | 21 (19–24) | 21 (19–23) |
Baseline WHO (%) | ||
Stage 1 | 548 (50) | 28 (48) |
Stage 2 | 217 (20) | 14 (24) |
Stage 3 | 233 (21) | 10 (17) |
Stage 4 | 97 (9) | 6 (10) |
Follow up time (years), median (IQR) | 1.7 (1.0–2.6) | |
Presentation of gynecomastia | ||
Unilateral | 28 (38) | |
Bilateral | 43 (59) | |
Unknown | 2 (3) | |
Outcomes | ||
Complete resolution | 28 (38) | |
Partial resolution | 43 (59) | |
Non resolution | 2 (3) | |
Unknown | 5 (7) |